Current Advanced on Hematopoietic Stem Cell: History
View Latest Version
Please note this is an old version of this entry, which may differ significantly from the current revision.
Subjects: Hematology | Cell & Tissue Engineering
Contributor:
Sergio Bydlowski

Blood is a connective tissue made up of approximately 34% cells and 66% plasma, transporting nutrients, gases and molecules in general to the whole body. Hematopoiesis is the main function of bone marrow. Human hematopoietic stem and progenitor cells reside in the bone marrow microenvironment, making it a hotspot for the development of hematopoietic diseases. Numerous alterations that correspond to disease progression have been identified in the bone marrow stem cell niche. Complex interactions between the bone marrow microenvironment and hematopoietic stem cells determine the balance between the proliferation, differentiation and homeostasis of the stem cell compartment. Changes in this tightly regulated network can provoke malignant transformation. However, our understanding of human hematopoiesis and the associated niche biology remains limited due to accessibility to human material and the limits of in vitro culture models. Traditional culture systems for human hematopoietic studies lack microenvironment niches, spatial marrow gradients, and dense cellularity, rendering them incapable of effectively translating marrow physiology ex vivo.

  • hematopoiesis
  • stem cell

1. Introduction

Hematopoiesis is the process by which blood cells are formed, replenishing the blood system over the life of an individual. The hematopoietic process is a highly hierarchical phenomenon, in which hematopoietic stem cell (HSCs) differentiation and proliferation are of vital importance. Each cell within the hematopoietic hierarchy can be distinguished based on specific surface markers, which contain epitopes that are recognized by antibodies [1][2][3]. Figure 1 shows the main markers in human hematopoietic hierarchy. The hematopoietic process in humans starts in the yolk sac (mesoblastic phase). Then, it is transferred to the liver and spleen. Finally, the bone marrow becomes the main organ responsible for hematopoiesis. In the bone marrow, HSCs have the capacity of unlimited self-renewal, producing progeny that is the same as the original cell. They are generally in the G0 phase of the cell cycle and have the capacity to differentiate into specialized cells.
Cells 08 01628 g001 550
Figure 1. Hierarchy of human hematopoiesis. LT-HSC: Long Term-Hematopoietic Stem Cell; ST-HSC: Short Term-Hematopoietic Stem Cell; MPP: Multipotent Progenitor; OPP: Oligopotent Progenitor; LRP: Lineage Restricted Progenitor; MEC: Mature Effector Cell. The markers of the most important lineages are listed: Common Lymphoid Progenitor (CLP); Common Myeloid Progenitor (CMP); Megakaryocyte-Erythrocyte Progenitor (MEP); Granulocyte-Macrophage Progenitor (GMP). Restricted lineage progenitor cells: Megakaryocyte Progenitor (MkP); Erythrocytic Progenitor (EryP); Granulocytic Progenitor (GrP); Monocyte Progenitor (MncP); Dendritic Progenitor Cell (Pro DC); Progenitor Cell-T (Pro-T); Progenitor Cell-B (Pro-B); Progenitor Cell-Nk (Pro-Nk).

2. Hematopoietic Stem Cells

The medullary microenvironment participates in the quiescence, self-renewal, proliferation, maturation and apoptosis of HSCs and contains several cells (i.e., mesenchymal stem cells, endothelial cells, fibroblasts, osteoblasts, reticular cells, adipocytes). These cells are sources of cytokines, growth factors, glycoproteins and glycosaminoglycans, among other regulators. Different combinations of these molecules lead to the formation of specific microenvironments within the medullary cavity, known as niches [4]. Histologically defined microenvironments are subdivided into four regions: endosteal, subendosteal, central, and perisinusoidal. Granulocytes and monocytes are found in all regions of the bone marrow, whereas erythroblasts proliferate preferentially in the central region [5]. Concerning the dynamics of the lymphoid lineage, B lymphocyte precursors are found in the subendosteal region, gradually decreasing toward the central region, whereas mature B cells are found throughout the bone marrow [6]. HSCs are located in the endosteal region, also known as the osteoblastic niche, but studies suggest that HSCs may migrate to the perisinusoidal region or vascular niche and remain quiescent or differentiate depending on the needs of the organism [2][5][7][8][9]. In fact, studies with new markers for HSCs and niche cells, new image techniques, including labeling protocols, have shown that most HSCs reside adjacent to sinusoidal vessels, leading to the proposed existence of a perivascular niche for HSCs [10]. It is assumed that in the bone marrow, there are at least two different niches: the endosteal niche, which would harbor quiescent HSCs, and the perivascular niche, which would harbor cycling HSCs [11]. Although most studies have been done on non-humans, researchers suppose that the data reflect what happens in humans. It has previously been proposed that HSCs are maintained in the endosteal (osteoblastic) niche; however, the available evidence does not seem to support this model. Nevertheless, the endosteal niche seems to support the maintenance of a subset of lymphoid progenitors [10]. Approximately 80% of dividing and non-dividing HSCs have been described to be associated with sinusoidal vessels, with another 10% of HSCs being adjacent to arterioles, and almost another 10% in transition zone vessels [10]. A small percentage of HSCs are located in the endosteum. In fact, a quantitative model of cellular components that could define these microenvironments, and the preferential location of HSCs in the bone marrow are still lacking [12]. Obstacles to recognizing the HSCs in the bone marrow include the low frequencies at which HSCs are found in the bone marrow and the cellular complexity of the bone marrow microenvironment.
Cell signaling in the HSC niche is a complex process and passes through an extensive signaling network balancing self-renewal and differentiation [13]. This signaling involves several substances, such as growth factors and cytokines that are secreted by both the medullary stroma cells and hematopoietic stem cells and are important signaling factors for hematopoiesis, proliferation, and differentiation [14].
The Jak/STAT, Ras/Erk, and PI3K/Akt signaling pathways have been described as important inducers of erythropoiesis transduction by activation of the erythropoietin receptor, and these intracellular pathways are responsible for the survival, proliferation, and differentiation of normal erythropoietic progenitors [15].
Other intracellular signaling pathways that are important for the control of hematopoiesis have been described, such as the Notch, Wingless-type (Wnt), and Hedgehog pathways [16], which have been associated with self-renewal and maintenance of HSCs. Notch proteins are highly conserved receptors on the surface of the cell membrane that regulate the development of stem cells, and mutations in this receptor may cause leukemia [17] and breast cancer [18]. Activation of the Notch pathway is necessary to keep HSCs undifferentiated. This pathway is more active in HSCs and less active in differentiated cells. Inhibition of the Notch pathway potentiates the differentiation of HSCs and loss of the bone marrow reconstitution capacity of sub-lethally irradiated animals; thus, Notch has been used as a marker of undifferentiated HSCs [19]. Wnt protein regulates several phenomena during fetal development, and this protein has been related to the self-renewal of stem cells [20]. Hedgehog (Hh) protein has been described as regulating embryonic and adult stem cell activity. In mammals, three genes are known to be responsible for this protein—Sonic Hedgehog (SHh), Indian Hedgehog (IHh), and Desert Hedgehog (DHh) [21][22].
Soluble factors are also closely associated with the maintenance and regulation of the undifferentiated state of HSCs in the bone marrow of adults, in addition to regulating the proliferation and differentiation of this population. Stromal-cell-derived factor-1 (SDF-1/CXCL12) and its CXCR4 linker are activated to recruit endothelial progenitor cells (EPCs) and regulate HSCs [2][13][23]. Other soluble factors act to promote the maintenance of HSCs in their niche; for example, the stem cell factor (SCF/Kit-ligand) and its c-Kit receptor (CD117) are both required by HSCs for their maintenance. SCF is an important soluble cytokine for hematopoiesis, and THE c-Kit receptor is expressed on the HSCs surface; altered forms of this receptor have been associated with several types of cancer [24][25]. Thrombopoietin (TPO) and its MPL ligand are also important soluble factors necessary for the maintenance of HSCs in their niche. TPO is a primary physiological regulator responsible for the stimulation of platelet production, a primary dominant factor and megakaryocytopoiesis stimulator. In addition, recent in vitro studies have shown that TPO alone or in combination with growth factors, such as a c-Kit ligand, IL-3, or even Flt-3, stimulates the proliferation of hematopoietic progenitor cells [26][27]. Many other factors also modulate the function of HSCs but are not necessarily required, such as angiogenin, angiopoietin-1, G-CSF, IL-6, and TGFβ, among others [25].

3. 3D Hematopoietic Stem Cell Culture

Cell culture in 2D format is simple and provides excellent material for studying homogeneous populations [28]. However, it does not consider several other important parameters of cell physiology, such as cell–cell communication or communication between the cell and microenvironment or adjacent molecules [29]. Therefore, the major problem with 2D cell culture is its limits [30]. One of the main criticisms of this study format is that animal physiology cannot be mimicked using only one layer of cells, which certainly does not correspond to the original tissue considering the complexity of the cellular microenvironment in the tissue of origin [31].
As an alternative to the technical limitations of 2D cell culture, 3D cell culture allows a better simulation of the in vivo structural complexity, replicating several characteristics present in tissues (Figure 2B,D), not only the interaction of cells with their microenvironment, but also morphology, differentiation, polarity, proliferation rate, gene expression profiles, and cell heterogeneity [32][33][34][35]. In fact, 3D culture has proven to be a realer model for translating research results into in vivo applications.
Current 3D cell culture models and methods include spheroids, organoids, microcarrier cultures, organs-on-chips, and 3D bioprinting [36][37]. Organotypic explant culture methods are used mostly when a technical/specific requirement of the tissue is to be studied and mimicked [38]. However, although the complexity of the 3D system is evident, some criteria must be considered and cannot be disregarded, such as the choice of material for the scaffold and hydrogels and cell type and culture methods, which vary considerably according to the tissue studied [37].
Organoid culture is most commonly used to describe constructs derived from pluripotent stem cells (embryonic or induced cells) or adult stem cells from various organs, including the hematopoietic tissue [39]. Organoid culture is classified as either tissue organoids (i.e., organotypic) or stem cells depending on how the cell layers are formed [40]. Organotypic tissue refers to free stromal cells without parenchyma, and its application is mainly with epithelial cells because of their high intrinsic ability to self-organize. With this method, it is possible to study HSCs, and Christopher et al. [41] were able to produce mature T cells from stem cells and hematopoietic progenitors in a thymus organoid culture.
Spheroid culture models simulate the microenvironment conditions of a living cell. Compared to the classic 2D model, the spheroid culture model emphasizes the interactions between cells and their relationship to the extracellular matrix (ECM) [42][43]. Tissues are not composed of a homogeneous population of cells; they are complex structures formed by several different components, with an intricate relationship such as vessels, nerves, and stroma, which should be considered in any kind of tissue engineering. This complex interaction between cells and the extracellular compartment requires a 3D environment to best represent these interactions [44][45].
Spheroid cell culture can be used in scaffold and scaffold-free models. The scaffold methods comprise hydrogel support, decellularized extracellular matrix, and resistant polymeric material support. Hydrogel consists of polymeric groups with a water-swollen hydrophilic structure [46]. Depending on their nature, these compounds are classified into different categories, including ECM protein–containing hydrogels (ECMPs), natural hydrogels, or synthetic hydrogels, each one with its own properties [47][48]. The decellularization technique consists of removing cells from the native tissue by chemical treatment, preserving the ECM. The tissue can then be replenished with cultured cells and grafted in vivo or used for ex vivo cell differentiation. In contrast to artificial scaffolds, decellularized scaffolds preserve the vascular structure, tridimensional niches, and chemical composition of bone marrow. Extracellular matrix components are directly related to several important factors for cell survival support, including cell behavior, signaling for survival, and proliferation, among others. Resistant polymeric material supports are structures similar to fibers or sponges. Cells maintained in this type of support exhibit a physiological behavior close to that of native tissue (such as those of cartilaginous tissue). Regarding the polymeric support, the most commonly used material is polystyrene, but biodegradable supports such as polycaprolactone have also been employed.
The development of a bioprinting system for the bone marrow microenvironment is important since it cannot be mimicked by methods such as organoids. Advanced 3D bone marrow models could serve for several different studies, including hematopoietic regulation, BM, MSCs, HSC interaction and expansion, interactions of hematological cancer cells, and evolution of several hematological diseases. In addition, these models could be used as a platform for expanding HSCs for transplantation. However, it is difficult to obtain a reliable BM model because of several critical technical challenges, from currently available 3D printing techniques to the possibility of precisely mimicking the different BM niches [49].
Relatively few studies have been done using hematopoietic stem cells in these methods. Decellularization of cartilaginous tissues has been tested for ex vivo culturing of hematopoietic cells [50]. A co-culture model of hematopoietic stem/progenitor cell (HSPC) spheroids using polydimethylsiloxane (PDMS) has shown that the effectiveness of three-dimensional culture for HSPC expansion for clinical use is still a strategy that needs further improvement [51].
A three-dimensional collagen-based culture using HSPC, bone-marrow-derived MSCs or the umbilical cord (UC) to mimic the main compartments of the bone marrow hematopoietic niche has been proposed [52]. Data analysis generated the following compartments: (I) HSPC in suspension above collagen and (II) migratory HSPC in collagen fiber matrix. The different sites were representative of the distinct microenvironments that make up the bone marrow and have a significant impact on the fate of HSPC. The authors suggested that this 3D culture system using collagen and BM-MSC allowed HSPC expansion and provided a potential platform for advanced study of niches and hematopoiesis and their regulatory mechanisms.
A bone marrow composed of two compartments, solid and liquid, that act harmoniously, has been proposed [53]. A bone marrow structure was created using a macroporous PEG hydrogel that resembled the macroporous 3D architecture of the trabecular bone, site of the red bone marrow, and, therefore, where the HSPC niches are located. This bone marrow analog was found to be suitable for HSPC culture and for enhancing HSPC expansion compared to conventional 2D cell culture. The developed model of a perfused 3D bone marrow analogue mimicked the HSCs niche under steady-state or activated cell conditions that favor the maintenance or differentiation, respectively, of HSCs and allowed drug testing [53] It was concluded that the system reflected the behavior of HSPC in the niche under physiological conditions.
Some studies have shown that the interaction of bone marrow stromal cells with leukemic cells increases the resistance of these leukemic cells. Numerous scaffolds have been created to provide a minimal structure based on the 3D leukemic microenvironment [44]. As 3D culture could result in resistance to drugs, it can be a good screening tool for drug evaluation prior to the administration of chemotherapic drugs [45][54]. A classic example of scaffolds used to recreate the leukemic niche is polycaprolactone, which is an aliphatic and biodegradable polyester with good biocompatibility [55][56].
Recently, a scaffold of degradable zwitterionic hydrogel was tested for human HSPC expansion [57]. A 73-fold increase of long-term hematopoietic stem cells was observed (LT-HSC). The viscoelasticity and smoothness of the highly hydrated zwitterionic hydrogels seems to be important for the creation of cell niches, by their unique mechanical and antifouling properties.
The organs-on-chips technique was developed to study the mechanical and physiological response of a tissue, combining concepts of tissue engineering and microfluidics [58]. A bioelectronic device based on a conductive polymer scaffold was integrated with an electrochemical transistor configuration that allows 3D cell growth and the real-time monitoring of cell adhesion and growth.
This technique consists of manipulating small amounts (10−9 to 10−18 L) of fluids using small openings with micrometer dimensions. This methodology has been widely reported because it offers several advantages, such as using small amounts of samples and reagents, performing separations and detections with high resolution, and a short time for analysis [32]. Such techniques allow the precise control of fluids and particles in a given cell culture. This culture method enables the control of such nanoliter-scale fluids as described above and further enables and facilitates the simultaneous manipulation of cultured cells from a single cell [33]. Through precise manipulation of the components of the microfluidic culture medium, it is possible to transport nutrients, hormones, and oxygen growth factors to facilitate homeostasis and recreate mechanical signals that are absent in traditional culture [59].
This cell culture system offers several advantages for basic research applications, including the precision of micromanufacturing, which allows the presentation of a controllable and reproducible microenvironment [35]. Another advantage of this model is that it provides complete control over the conditions of the cell culture, including dynamic cell control, nutrient addition, removal of metabolites, stimulation with drugs and proteins, and simultaneous image and chip format [33][60][61].
The organs-on-chips technique was described in cancer studies (cancer-on-chip), where it can replicate the microenvironment to achieve robust and reliable results [62][63]. However, up to now, it has been difficult to culture HSCs in an organs-on-chips model. A device with a central cavity that successfully mimics the bone and bone marrow has been described. This device is made from polydimethylsiloxane (PDMS) with bone inducers inserted. The central chamber of this device is composed of porous PDMS membranes, and cytokines are added in the microfluids [64]. Although several methods have been used, results using HSCs are generally poor [65].

This entry is adapted from the peer-reviewed paper 10.3390/cells8121628

References

  1. Ng, A.P.; Alexander, W.S. Haematopoietic stem cells: Past, present and future. Cell Death Discov. 2017, 3, 17002.
  2. Chotinantakul, K.; Leeanansaksiri, W. Hematopoietic stem cell development, niches, and signaling pathways. Bone Marrow Res. 2012, 2012, 270425.
  3. Wasnik, S.; Tiwari, A.; Kirkland, M.A.; Pande, G. Osteohematopoietic stem cell niches in bone marrow. Int. Rev. Cell Mol. Biol. 2012, 298, 95–133.
  4. Bianco, P.; Robey, P.G. Stem cells in tissue engineering. Nature 2001, 414, 118–121.
  5. Calvi, L.M.; Link, D.C. Cellular complexity of the bone marrow hematopoietic stem cell niche. Calcif. Tissue Int. 2014, 94, 112–124.
  6. Nilsson, S.K.; Johnston, H.M.; Coverdale, J.A. Spatial localization of transplanted hemopoietic stem cells: Inferences for the localization of stem cell niches. Blood 2001, 97, 2293–2299.
  7. Kiel, M.J.; Morrison, S.J. Maintaining hematopoietic stem cells in the vascular niche. Immunity 2006, 25, 862–864.
  8. Orkin, S.H.; Zon, L.I. Hematopoiesis: An evolving paradigm for stem cell biology. Cell 2008, 132, 631–644.
  9. Calvi, L.M.; Adams, G.B.; Weibrecht, K.W.; Weber, J.M.; Olson, D.P.; Knight, M.C.; Martin, R.P.; Schipani, E.; Divieti, P.; Bringhurst, F.R.; et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425, 841–846.
  10. Oh, I.H.; Kwon, K.R. Concise review: Multiple niches for hematopoietic stem cell regulations. Stem Cells 2010, 28, 1243–1249.
  11. Crane, G.M.; Jeffery, E.; Morrison, S.J. Adult haematopoietic stem cell niches. Nat. Rev. Immunol. 2017, 17, 573–590.
  12. Nies, C.; Gottwald, E. Advances in Tissue Engineering and Regenerative Medicine Artificial Hematopoietic Stem Cell Niches-Dimensionality Matters. Adv. Tissue Eng. Regen. Med. 2017, 2, 42.
  13. Gomariz, A.; Isringhausen, S.; Helbling, P.M.; Nombela-Arrieta, C. Imaging and spatial analysis of hematopoietic stem cell niches. Ann. N. Y. Acad. Sci. 2019.
  14. Blank, U.; Karlsson, G.; Karlsson, S. Signaling pathways governing stem-cell fate. Blood 2008, 111, 492–503.
  15. Majka, M.; Janowska-Wieczorek, A.; Ratajczak, J.; Ehrenman, K.; Pietrzkowski, Z.; Kowalska, M.A.; Gewirtz, A.M.; Emerson, S.G.; Ratajczak, M.Z. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001, 97, 3075–3085.
  16. Jafari, M.; Ghadami, E.; Dadkhah, T.; Akhavan-Niaki, H. PI3k/AKT signaling pathway: Erythropoiesis and beyond. J. Cell. Physiol. 2019, 234, 2373–2385.
  17. Cerdan, C.; Bhatia, M. Novel roles for Notch, Wnt and Hedgehog in hematopoesis derived from human pluripotent stem cells. Int. J. Dev. Biol. 2010, 54, 955–963.
  18. Aster, J.C.; Pear, W.S.; Blacklow, S.C. Notch signaling in leukemia. Annu. Rev. Pathol. 2008, 3, 587–613.
  19. Tekmal, R.R.; Keshava, N. Role of MMTV integration locus cellular genes in breast cancer. Front. Biosci. 1997, 2, 519–526.
  20. Duncan, A.W.; Rattis, F.M.; DiMascio, L.N.; Congdon, K.L.; Pazianos, G.; Zhao, C.; Pazianos, G.; Zhao, C.; Yoon, K.; Cook, J.M.; et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol. 2005, 6, 314–322.
  21. Gordon, M.D.; Nusse, R. Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem. 2006, 281, 22429–22433.
  22. Dyer, M.A.; Farrington, S.M.; Mohn, D.; Munday, J.R.; Baron, M.H. Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. Development 2001, 128, 1717–1730.
  23. Shi, X.; Wei, S.; Simms, K.J.; Cumpston, D.N.; Ewing, T.J.; Zhang, P. Sonic Hedgehog Signaling Regulates Hematopoietic Stem/Progenitor Cell Activation during the Granulopoietic Response to Systemic Bacterial Infection. Front. Immunol. 2018, 9, 349.
  24. Mendez-Ferrer, S.; Michurina, T.V.; Ferraro, F.; Mazloom, A.R.; Macarthur, B.D.; Lira, S.A.; Scadden, D.T.; Ma’ayan, A.; Enikolopov, G.N.; Frenette, P.S. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466, 829–834.
  25. McNiece, I.K.; Briddell, R.A. Stem cell factor. J. Leukoc. Biol. 1995, 58, 14–22.
  26. Edling, C.E.; Hallberg, B. c-Kit--a hematopoietic cell essential receptor tyrosine kinase. Int. J. Biochem. Cell Biol. 2007, 39, 1995–1998.
  27. Nakamura-Ishizu, A.; Takizawa, H.; Suda, T. The analysis, roles and regulation of quiescence in hematopoietic stem cells. Development 2014, 141, 4656–4666.
  28. Ravi, M.; Paramesh, V.; Kaviya, S.R.; Anuradha, E.; Solomon, F.D. 3D cell culture systems: Advantages and applications. J. Cell Physiol. 2015, 230, 16–26.
  29. Murray-Dunning, C.; McArthur, S.L.; Sun, T.; McKean, R.; Ryan, A.J.; Haycock, J.W. Three-dimensional alignment of schwann cells using hydrolysable microfiber scaffolds: Strategies for peripheral nerve repair. Methods Mol. Biol. 2011, 695, 155–166.
  30. Tee, D.E.H. Culture of Animal Cells: A Manual of Basic Technique. J. R. Soc. Med. 1984, 77, 902–903.
  31. Melissinaki, V.; Gill, A.A.; Ortega, I.; Vamvakaki, M.; Ranella, A.; Haycock, J.W.; Fotakis, C.; Farsari, M.; Claeyssens, F. Direct laser writing of 3D scaffolds for neural tissue engineering applications. Biofabrication 2011, 3, 045005.
  32. Whitesides, G.M. The origins and the future of microfluidics. Nature 2006, 442, 368–373.
  33. Mehling, M.; Tay, S. Microfluidic cell culture. Curr. Opin. Biotechnol. 2014, 25, 95–102.
  34. El-Ali, J.; Sorger, P.K.; Jensen, K.F. Cells on chips. Nature 2006, 442, 403–411.
  35. Dittrich, P.S.; Manz, A. Lab-on-a-chip: Microfluidics in drug discovery. Nat. Rev. Drug Discov. 2006, 5, 210–218.
  36. Pampaloni, F.; Reynaud, E.G.; Stelzer, E.H. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 2007, 8, 839–845.
  37. Haycock, J.W. 3D cell culture: A review of current approaches and techniques. Methods Mol. Biol. 2011, 695, 1–15.
  38. Toda, S.; Watanabe, K.; Yokoi, F.; Matsumura, S.; Suzuki, K.; Ootani, A.; Aoki, S.; Koike, N.; Sugihara, H. A new organotypic culture of thyroid tissue maintains three-dimensional follicles with C cells for a long term. Biochem. Biophys. Res. Commun. 2002, 294, 906–911.
  39. Lancaster, M.A.; Huch, M. Disease modelling in human organoids. Dis. Model Mech. 2019, 12.
  40. Lancaster, M.A.; Knoblich, J.A. Organogenesis in a dish: Modeling development and disease using organoid technologies. Science 2014, 345, 1247125.
  41. Seet, C.S.; He, C.; Bethune, M.T.; Li, S.; Chick, B.; Gschweng, E.H.; Zhu, Y.; Kim, K.; Kohn, D.B.; Baltimore, D.; et al. Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids. Nat. Methods 2017, 14, 521–530.
  42. Yuhas, J.M.; Li, A.P.; Martinez, A.O.; Ladman, A.J. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res. 1977, 37, 3639–3643.
  43. Fennema, E.; Rivron, N.; Rouwkema, J.; van Blitterswijk, C.; de Boer, J. Spheroid culture as a tool for creating 3D complex tissues. Trends Biotechnol. 2013, 31, 108–115.
  44. Tanner, K.; Gottesman, M.M. Beyond 3D culture models of cancer. Sci. Transl. Med. 2015, 7, 283ps9.
  45. Gillet, J.P.; Calcagno, A.M.; Varma, S.; Marino, M.; Green, L.J.; Vora, M.I.; Patel, C.; Orina, J.N.; Eliseeva, T.A.; Singal, V.; et al. Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc. Natl. Acad. Sci. USA 2011, 108, 18708–18713.
  46. Li, Y.; Huang, G.; Li, M.; Wang, L.; Elson, E.L.; Jian Lu, T.; Genin, G.M.; Xu, F. An approach to quantifying 3D responses of cells to extreme strain. Sci. Rep. 2016, 6, 19550.
  47. Polymeric Scaffolds in Tissue Engineering Application: A Review. Int. J. Polymer Sci. 2011, 2011.
  48. Kleinman, H.K.; Philp, D.; Hoffman, M.P. Role of the extracellular matrix in morphogenesis. Curr. Opin. Biotechnol. 2003, 14, 526–532.
  49. Raic, A.; Naolou, T.; Mohra, A.; Chatterjee, C.; Lee-Thedieck, C. 3D models of the bone marrow in health and disease: Yesterday, today and tomorrow. MRS Commun. 2019, 9, 37–52.
  50. Llames, S.; Garcia, E.; Otero Hernandez, J.; Meana, A. Tissue bioengineering and artificial organs. Adv. Exp. Med. Biol. 2012, 741, 314–336.
  51. Futrega, K.; Atkinson, K.; Lott, W.B.; Doran, M.R. Spheroid Coculture of Hematopoietic Stem/Progenitor Cells and Monolayer Expanded Mesenchymal Stem/Stromal Cells in Polydimethylsiloxane Microwells Modestly Improves In Vitro Hematopoietic Stem/Progenitor Cell Expansion. Tissue Eng. Part C Methods. 2017, 23, 200–218.
  52. Leisten, I.; Kramann, R.; Ventura Ferreira, M.S.; Bovi, M.; Neuss, S.; Ziegler, P.; Wagner, W.; Knüchel, R.; Schneider, R.K. 3D co-culture of hematopoietic stem and progenitor cells and mesenchymal stem cells in collagen scaffolds as a model of the hematopoietic niche. Biomaterials 2012, 33, 1736–1747.
  53. Rodling, L.; Schwedhelm, I.; Kraus, S.; Bieback, K.; Hansmann, J.; Lee-Thedieck, C. 3D models of the hematopoietic stem cell niche under steady-state and active conditions. Sci. Rep. 2017, 7, 4625.
  54. Reticker-Flynn, N.E.; Malta, D.F.; Winslow, M.M.; Lamar, J.M.; Xu, M.J.; Underhill, G.H.; Hynes, R.O.; Jacks, T.E.; Bhatia, S.N. A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat. Commun. 2012, 3, 1122.
  55. Chen, Y.; Gao, D.; Wang, Y.; Lin, S.; Jiang, Y. A novel 3D breast-cancer-on-chip platform for therapeutic evaluation of drug delivery systems. Anal. Chim. Acta 2018, 1036, 97–106.
  56. Song, K.; Wang, Z.; Liu, R.; Chen, G.; Liu, L. Microfabrication-Based Three-Dimensional (3-D) Extracellular Matrix Microenvironments for Cancer and Other Diseases. Int. J. Mol. Sci. 2018, 19, 935.
  57. Wu, J.; Xiao, Y.; Chen, A.; He, H.; He, C.; Shuai, X.; Li, X.; Chen, S.; Ren, B.; Zheng, J.; et al. Sulfated zwitterionic poly(sulfobetaine methacrylate) hydrogels promote complete skin regeneration. Acta Biomater. 2018, 71, 293–305.
  58. Yi, H.G.; Lee, H.; Cho, D.W. 3D Printing of Organs-On-Chips. Bioengineering 2017, 4, 10.
  59. Ozbolat, I.T. Bioprinting scale-up tissue and organ constructs for transplantation. Trends Biotechnol. 2015, 33, 395–400.
  60. Novo, P.; Volpetti, F.; Chu, V.; Conde, J.P. Control of sequential fluid delivery in a fully autonomous capillary microfluidic device. Lab. Chip. 2013, 13, 641–645.
  61. Ong, S.M.; Zhang, C.; Toh, Y.C.; Kim, S.H.; Foo, H.L.; Tan, C.H.; van Noort, D.; Park, S.; Yu, H. A gel-free 3D microfluidic cell culture system. Biomaterials 2008, 29, 3237–3244.
  62. Zhang, Y.S.; Duchamp, M.; Oklu, R.; Ellisen, l.W.; Langer, R.; Khademhosseini, A. Bioprinting the Cancer Microenvironment. ACS Biomater Sci. Eng. 2016, 2, 1710–1721.
  63. Shafiee, A.; Atala, A. Printing Technologies for Medical Applications. Trends Mol. Med. 2016, 22, 254–265.
  64. Torisawa, Y.S.; Spina, C.S.; Mammoto, T.; Mammoto, A.; Weaver, J.C.; Tat, T.; Collins, J.J.; Ingber, D.E. Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro. Nat. Method. 2014, 11, 663–669.
  65. Di Maggio, N.; Piccinini, E.; Jaworski, M.; Trumpp, A.; Wendt, D.J.; Martin, I. Toward modeling the bone marrow niche using scaffold-based 3D culture systems. Biomaterials 2011, 32, 321–329.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
This entry is offline, you can click here to edit this entry!
Video Production Service
Feedback